Follow the Paxman AB (publ) stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Paxman AB (publ) has recorded 27 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 26 August 2026 (Purchase). Among the most active insiders: Per-Anders Johansson. All data is free.
27
Insider Decl.
n/a
Thresholds
€812,120
23 ops.
Buy Volume
€12m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Paxman AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 93.50.
38Σ signal
Buys €812,120€12m Sells
Fundamental score
Ranked 20,987 of 29,062 companies
36.8
score / 100
Value
22
Quality
52
FCF yld-1.2%
Earn yld-1.3%
EV/EBITDA44.0x
ROE-1.3%
Gross mgn67%
Net mgn-5.3%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,100 shares@ €7.11030.0084% mcap14.6% of flowAktieISINISIN SE0009806284FI:A003R939-1
25 of 27 declarations
Acerca de Paxman AB (publ)
Paxman AB (publ) es una empresa sueca enfocada en el desarrollo de soluciones para el manejo de los efectos secundarios de la quimioterapia. Cotiza en la Bolsa de Estocolmo (XSTO).